Artivion (AORT) Income from Continuing Operations (2010 - 2026)
Artivion (AORT) posted Income from Continuing Operations of 1417000.0 for Q1 2026, down 41.59% on a QoQ basis from 2426000.0 in Q4 2025, and up 380.59% year-over-year from 294843.43 in Q1 2025.
Artivion (AORT) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Artivion's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 1417000.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 380.59% year-over-year to 1417000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11690000.0 (up 154.63% YoY) and the FY2025 annual result came in at 9768000.0, up 173.12% from the prior year.
- Income from Continuing Operations was 1417000.0 for Q1 2026 at Artivion, down from 2426000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 7533000.0 in Q1 2024 and bottomed at 16483000.0 in Q4 2024.
- A 5-year average of 3062117.65 and a median of 2288000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations slumped 314.67% — and 2025, when it soared 384.18%.
- Artivion's Income from Continuing Operations stood at 2169000.0 in 2022, then slumped by 283.26% to 3975000.0 in 2023, then slumped by 314.67% to 16483000.0 in 2024, then jumped by 114.72% to 2426000.0 in 2025, then slumped by 41.59% to 1417000.0 in 2026.
- Business Quant data shows AORT's Income from Continuing Operations at 1417000.0 in Q1 2026, 2426000.0 in Q4 2025, and 6502000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | 1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | -505,000.00 |
| Dec 31, 2024 | -16.48 Mn |
| Sep 30, 2024 | -2.29 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | -3.98 Mn |
| Sep 30, 2023 | -9.80 Mn |
| Jun 30, 2023 | -3.38 Mn |
| Mar 31, 2023 | -13.53 Mn |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | -13.71 Mn |
| Jun 30, 2022 | -4.26 Mn |
| Mar 31, 2022 | -3.39 Mn |
| Dec 31, 2021 | -20.10 Mn |
| Sep 30, 2021 | 10.58 Mn |
| Jun 30, 2021 | -2.18 Mn |